Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Pharmacol Res. 2021 May 4;169:105653. doi: 10.1016/j.phrs.2021.105653

Fig. 6. Agonist pharmacology displayed by Zn2+ and H+ at ZACAla128 expressed in oocytes.

Fig. 6.

A. Agonist properties displayed by Zn2+ at ZACAla128. Representative traces for Zn2+-evoked currents in ZACAla128-expressing oocytes (left) and averaged concentration-relationships for Zn2+ at ZACThr128 and ZACAla128 (means ± S.E.M., n = 7–8) (right). B. Agonist properties displayed by H+ at ZACAla128. Representative traces for H+-evoked currents in ZACAla128-expressing oocytes (left) and averaged concentration-relationships for H+ at ZACThr128 and ZACAla128 (means ± S.E.M., n = 6) (right).